Search filters

List of works by Simone Ferrero

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines

scientific article published on 28 February 2019

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.

scientific article published on 22 February 2018

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

scientific article published on 29 May 2018

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.

scientific article

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

scientific article published on 4 February 2015

Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study

scientific article published on 9 January 2018

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study

scientific article published on 22 April 2016

Data quality improvement of a multicenter clinical trial dataset

scientific article published in July 2017

Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.

scientific article published in January 2018

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

scientific article published on 10 July 2019

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis

scientific article published on 4 December 2017

HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data

scientific article published on 23 November 2017

Highly sensitive MYD88L265P mutation detection by droplet digital PCR in Waldenström Macroglobulinemia.

scientific article published on 22 March 2018

How to manage mantle cell lymphoma.

scientific article published on 23 May 2014

How to treat old MCL patients: one size fits it all?

scientific article

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease

scientific article published on 07 September 2020

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.

scientific article published on 10 January 2012

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

scientific article published on 04 September 2018

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma.

scientific article

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

scientific article published on 5 July 2016

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

scientific article published on 16 July 2014

Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma

scientific article published on 22 March 2010

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.

scientific article published on 26 August 2015

Minimal Residual Disease in Indolent Lymphomas: A Critical Assessment

scientific article published on 06 November 2018

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network

scientific article published on 16 August 2019

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.

scientific article published on 13 October 2016

Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?

scientific article published on July 2017

Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes.

scientific article published on 29 December 2011

New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies

scientific article published on 18 September 2018

New paradigms in mantle cell lymphoma: is it time to risk-stratify treatment based on the proliferative signature?

scientific article

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders.

scientific article

Novel CALR somatic mutations in essential thrombocythaemia

scientific article published on 7 September 2015

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi

scientific article published on 08 July 2019

Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.

scientific article published on June 2015

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.

scientific article published on 2 April 2017

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma.

scientific article published on 6 October 2015

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial

scientific article published on 5 August 2015

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

scientific article

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

scientific article published on 12 January 2017

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program

article

Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.

scientific article published on 25 October 2011

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

scientific article

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

scientific article published on 08 November 2018

Paulina is supported by:

About Paulina

Help